rs767328866

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_020433.5(JPH2):​c.637C>T​(p.Arg213Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,432,604 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

JPH2
NM_020433.5 missense

Scores

1
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: 1.26
Variant links:
Genes affected
JPH2 (HGNC:14202): (junctophilin 2) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. Alternative splicing has been observed at this locus and two variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008232176).
BP6
Variant 20-44160150-G-A is Benign according to our data. Variant chr20-44160150-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 201797.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Benign=1, Uncertain_significance=2}. Variant chr20-44160150-G-A is described in Lovd as [Benign]. Variant chr20-44160150-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 2 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JPH2NM_020433.5 linkc.637C>T p.Arg213Trp missense_variant Exon 2 of 6 ENST00000372980.4 NP_065166.2 Q9BR39-1Q86VZ3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JPH2ENST00000372980.4 linkc.637C>T p.Arg213Trp missense_variant Exon 2 of 6 5 NM_020433.5 ENSP00000362071.3 Q9BR39-1

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
192
AN:
151650
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00447
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000329
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000961
GnomAD3 exomes
AF:
0.000374
AC:
19
AN:
50800
Hom.:
1
AF XY:
0.000301
AC XY:
9
AN XY:
29854
show subpopulations
Gnomad AFR exome
AF:
0.0137
Gnomad AMR exome
AF:
0.000406
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000422
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000908
Gnomad OTH exome
AF:
0.000639
GnomAD4 exome
AF:
0.000119
AC:
153
AN:
1280846
Hom.:
0
Cov.:
32
AF XY:
0.000105
AC XY:
66
AN XY:
629038
show subpopulations
Gnomad4 AFR exome
AF:
0.00458
Gnomad4 AMR exome
AF:
0.000494
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000182
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000387
Gnomad4 OTH exome
AF:
0.000266
GnomAD4 genome
AF:
0.00127
AC:
192
AN:
151758
Hom.:
2
Cov.:
32
AF XY:
0.00116
AC XY:
86
AN XY:
74174
show subpopulations
Gnomad4 AFR
AF:
0.00446
Gnomad4 AMR
AF:
0.000328
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000951
Alfa
AF:
0.00135
Hom.:
0
Bravo
AF:
0.00151
ExAC
AF:
0.000338
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:2
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 28, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: JPH2 c.637C>T (p.Arg213Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 in 50800 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 15 fold of the estimated maximal expected allele frequency for a pathogenic variant in JPH2 causing Cardiomyopathy phenotype (2.5e-05). To our knowledge, no occurrence of c.637C>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 201797). Based on the evidence outlined above, the variant was classified as likely benign. -

Jun 12, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Arg213Trp variant in JPH2 has not been previously reported in individuals with cardiomyopathy, but has been identified in 0.1% (4/3380) of South Asian chr omosomes and 1/82 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Computational prediction tools and conservatio n analysis do not provide strong support for or against an impact to the protein . In summary, the clinical significance of the p.Arg213Trp variant is uncertain. -

not provided Benign:3
May 14, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 01, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Hypertrophic cardiomyopathy 17;C5561970:Cardiomyopathy, dilated, 2E Uncertain:1
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

JPH2 NM_020433.4 exon 2 p.Arg213Trp (c.637C>T): This variant has not been reported in the literature but is present in 0.07% (64/81352) of total alleles in the Genome Aggregation Database, including 2 homozygotes (https://gnomad.broadinstitute.org/variant/20-42788790-G-A). This variant is present in ClinVar (Variation ID:201797). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Hypertrophic cardiomyopathy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 21, 2019
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0082
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.90
L
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.18
Sift
Uncertain
0.029
D
Sift4G
Benign
0.083
T
Polyphen
1.0
D
Vest4
0.31
MVP
0.73
ClinPred
0.027
T
GERP RS
3.1
Varity_R
0.11
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767328866; hg19: chr20-42788790; API